<DOC>
	<DOCNO>NCT01399463</DOCNO>
	<brief_summary>The aim study show safety efficacy SeQuent® Please ( Drug Eluting Balloon DEB ) vs. commonly use Drug Eluting Stents treatment small vessel disease side branch pressure wire guide percutaneous coronary intervention .</brief_summary>
	<brief_title>Pressure-wire Guided PTCA : Drug Eluting Stent Versus Drug Eluting Balloon ( WinDEB Study )</brief_title>
	<detailed_description>This study randomize , prospective , multi-center , efficacy study DES control group assess 6-month loss FFR patient treat `` matrix coat paclitaxel-eluting PTCA-balloon catheter '' SeQuent® Please commonly use DES small vessel de novo side branch lesion . 100 patient study total two equivalent treatment group DEB &amp; DES 50 patient .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Patients least 18 year age . Patients stable angina pectoris ( CCS class 13 ) unstable angina pectoris ( Braunwald class 12 , AC ) document ischemia document silent ischemia Patients must agree undergo angiographic 6month clinical followup 12 36 month . De novo coronary lesion include side branch native coronary artery ( reference vessel ≥ 2.0 ≤ 3.0 mm , lesion length ≤ 25 mm angiographically document ) Diameter stenosis pre procedure must either ≥ 70 % ≥ 50 % ischemia correspond target lesion document either exercise stress ECG , stress echocardiography , scintigraphy , MRT , suspect base angina pectoris . Fractional Flow Reserve ( FFR ) must less equal 0.75 . Patients life expectancy le 12 month Patients treat one DES last 12 month would allow 3month dual antiplatelet therapy patient randomize DEB treatment group . Patients oblige dual antiplatelet aggregation therapy 3 month follow study inclusion Patients acute ( &lt; 24 h ) recent ( 48 hour ) myocardial infarction Patients severe congestive heart failure severe heart failure NYHA IV severe valvular heart disease Patients demonstrate clinical sign cardiogenic shock time procedure ( systolic blood pressure le 80 mmHg require inotropic support , IABP and/or fluid challenge ) DES treat lesion ( ) last 12 month . Thrombus burden ( STEMI , NSTEMI ) and/or total occlusion culprit segment Insegment stenosis native vessel within 5 mm adjacent stent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Drug Eluting Stent , Drug Eluting Balloon , Fractional Flow Reserve , DES , DEB , FFR</keyword>
</DOC>